<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of Clinical and Experimental Neurology</journal-id><journal-title-group><journal-title xml:lang="en">Annals of Clinical and Experimental Neurology</journal-title><trans-title-group xml:lang="ru"><trans-title>Анналы клинической и экспериментальной неврологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-5473</issn><issn publication-format="electronic">2409-2533</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1274</article-id><article-id pub-id-type="doi">10.17816/ACEN.1274</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Metabolic predictors of ischemic stroke in young adults</article-title><trans-title-group xml:lang="ru"><trans-title>Метаболические предикторы течения ишемического инсульта у молодых</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5141-3292</contrib-id><name-alternatives><name xml:lang="en"><surname>Ponomareva</surname><given-names>Maria S.</given-names></name><name xml:lang="ru"><surname>Пономарева</surname><given-names>Мария Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>neurologist, Neurology and neurosurgery center, State Novosibirsk Regional Clinical Hospital; laboratory assistant, Neurology department, Novosibirsk State Medical University</p></bio><bio xml:lang="ru"><p>врач-невролог Центра неврологии и нейрохирургии Государственной Новосибирской областной клинической больницы; старший лаборант каф. неврологии Новосибирского государственного медицинского университета</p></bio><email>marisponn@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6951-2205</contrib-id><name-alternatives><name xml:lang="en"><surname>Shchepankevich</surname><given-names>Larisa A.</given-names></name><name xml:lang="ru"><surname>Щепанкевич</surname><given-names>Лариса Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Med.), Head, Neurology department, Novosibirsk State Medical University; Head, Neurology and neurosurgery center, State Novosibirsk Regional Clinical Hospital</p></bio><bio xml:lang="ru"><p>д-р мед. наук, зав. каф. неврологии Новосибирского государственного медицинского университета; зав. Центром неврологии и нейрохирургии Государственной Новосибирской областной клинической больницы</p></bio><email>marisponn@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4141-9161</contrib-id><name-alternatives><name xml:lang="en"><surname>Rerikh</surname><given-names>Ksenya V.</given-names></name><name xml:lang="ru"><surname>Рерих</surname><given-names>Ксения Викторовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>postgraduate student, Neurology department, Novosibirsk State Medical University; neurologist, Regional Vascular Center No. 2, State Novosibirsk Regional Clinical Hospital</p></bio><bio xml:lang="ru"><p>аспирант каф. неврологии Новосибирского государственного медицинского университета; врач-невролог Регионального сосудистого центра № 2 Государственной Новосибирской областной клинической больницы</p></bio><email>marisponn@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-3737-3431</contrib-id><name-alternatives><name xml:lang="en"><surname>Zatynko</surname><given-names>Andrey V.</given-names></name><name xml:lang="ru"><surname>Затынко</surname><given-names>Андрей Владимирович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Head, Stroke unit, Regional Vascular Center No. 2</p></bio><bio xml:lang="ru"><p>зав. отд. для больных с острыми нарушениями мозгового кровообращения Регионального сосудистого центра № 2 </p></bio><email>marisponn@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2373-2231</contrib-id><name-alternatives><name xml:lang="en"><surname>Antonova</surname><given-names>Ksenia V.</given-names></name><name xml:lang="ru"><surname>Антонова</surname><given-names>Ксения Валентиновна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Med.), leading researcher, 1<sup>st </sup>Neurological department, Institute of Clinical and Preventive Neurology</p></bio><bio xml:lang="ru"><p>д-р мед. наук, в. н. с. 1-го неврологического отд. Института клинической и профилактической неврологии </p></bio><email>marisponn@yandex.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5883-8119</contrib-id><name-alternatives><name xml:lang="en"><surname>Tanashyan</surname><given-names>Marine М.</given-names></name><name xml:lang="ru"><surname>Танашян</surname><given-names>Маринэ Мовсесовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Med.), Professor, Corr. Member of the Russian Academy of Sciences, Deputy Director for research, Head, 1<sup>st</sup> Neurological department, Institute of Clinical and Preventive Neurology</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор, член-корреспондент РАН, зам. директора по научной работе, рук. 1-го неврологического отд. Института клинической и профилактической неврологии </p></bio><email>marisponn@yandex.ru</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">State Novosibirsk Regional Clinical Hospital</institution></aff><aff><institution xml:lang="ru">Государственная Новосибирская областная клиническая больница</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Novosibirsk State Medical University</institution></aff><aff><institution xml:lang="ru">Новосибирский государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Research Center of Neurology</institution></aff><aff><institution xml:lang="ru">Научный центр неврологии</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2025-03-15" publication-format="electronic"><day>15</day><month>03</month><year>2025</year></pub-date><volume>19</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>21</fpage><lpage>29</lpage><history><date date-type="received" iso-8601-date="2025-01-22"><day>22</day><month>01</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-02-03"><day>03</day><month>02</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Ponomareva M.S., Shchepankevich L.A., Rerikh K.V., Zatynko A.V., Antonova K.V., Tanashyan M.М.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, Пономарева М.С., Щепанкевич Л.А., Рерих К.В., Затынко А.В., Антонова К.В., Танашян М.М.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Ponomareva M.S., Shchepankevich L.A., Rerikh K.V., Zatynko A.V., Antonova K.V., Tanashyan M.М.</copyright-holder><copyright-holder xml:lang="ru">Пономарева М.С., Щепанкевич Л.А., Рерих К.В., Затынко А.В., Антонова К.В., Танашян М.М.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://annaly-nevrologii.com/pathID/article/view/1274">https://annaly-nevrologii.com/pathID/article/view/1274</self-uri><abstract xml:lang="en"><p><bold>Introduction.</bold> Ischemic stroke (IS) has a tendency towards younger age of onset among working-age adults, with an increasing role of obesity in IS development. New prognostic markers affecting stroke severity and early outcomes are being sought.</p> <p><bold>Aim</bold>: to investigate etiology and risk factors of cryptogenic IS in working-age patients (18–50 years) and evaluate the significance of metabolic markers of obesity and hemostasis in predicting immediate disease outcomes.</p> <p><bold>Materials and methods. </bold>We retrospectively analyzed 343 medical records of acute stroke patients aged 18–50 years using clinical, laboratory, and imaging findings and calculated risk levels.</p> <p><bold>Results.</bold> Obesity was observed in more than half (51.3%) of the patients. Early atherosclerotic changes in the vessel wall were detected in 62.26% of the cases. Worse immediate stroke outcomes were associated with all obesity parameters: body mass index (r = 0.48), waist circumference (WC) (r = 0.43), waist-to-hip ratio (WHR) (r = 0.52), levels of glucose (r = 0.47), C-reactive protein (r = 0.34), hematocrit (r = 0.41), high-density lipoproteins (r = –0.32), von Willebrand factor (r = 0.58), fibrinogen (r = 0.66), FVIII (r = 0.50), D-dimer (r = 0.50), and ADP-induced platelet aggregation (r = 0.41). Stroke severity was found to correlate with levels of triglycerides (r = 0.57), low-density lipoproteins (r = 0.35), von Willebrand factor (r = 0.55), fibrinogen (r = 0.46), coagulation factor VIII (r = 0.63), D-dimer (r = 0.39), antithrombin III (r = 0.39), and WHR (r = 0.53). Receiver operating characteristic curves revealed triglyceride-glucose index to be a predictor of worse early outcome (area under the curve, 0.66; threshold, 4.7), including in terms of WC (0.68 and 497.6, respectively) or stroke severity (0.63 and 4.7, respectively).</p> <p><bold>Conclusion.</bold> IS in young adults is accompanied by impaired metabolism, affecting the disease outcome. Indices including glucose, triglycerides, and the obesity status can play a role in predicting the stroke severity in young adults, among others.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Введение</bold><bold>.</bold> Ишемический инсульт имеет тенденцию к омоложению у лиц трудоспособного возраста, при этом возрастает роль ожирения, способствующего реализации ИИ. Ведётся поиск новых прогностических маркеров, влияющих на тяжесть течения инсульта и ранние исходы.</p> <p><bold>Цель </bold>исследования: изучить этиологию и факторы риска ишемического инсульта неустановленной этиологии у пациентов трудоспособного возраста (18–50 лет), оценить прогностическую значимость метаболических маркеров, отражающих статус ожирения, гемостаза на ближайшие исходы заболевания.</p> <p><bold>Материалы и методы</bold><bold>. </bold>Проведён ретроспективный анализ 343 историй болезни пациентов в возрасте 18–50 лет в острейшем периоде нарушения мозгового кровообращения с использованием клинико-лабораторных, инструментальных показателей, с вычислением уровня риска.</p> <p><bold>Результаты</bold><bold>.</bold> Ожирение встречается более чем у половины (51,3%) пациентов. У 62,26% выявлены начальные атеросклеротические изменения стенки сосуда. Худшие ближайшие исходы инсульта были ассоциированы со всеми показателями статуса ожирения: индексом массы тела (r = 0,48), объёмом талии (ОТ; r = 0,43), соотношением ОТ и объёма бёдер (r = 0,52), уровнями гликемии (r = 0,47), С-реактивного белка (r = 0,34), гематокрита (r = 0,41), липопротеидов высокой плотности (r = –0,32), фактором фон Виллебранда (r = 0,58), фибриногеном (r = 0,66), FVIII (r = 0,50), D-димером (r = 0,50), агрегацией тромбоцитов с АДФ (r = 0,41). В отношении тяжести инсульта выявлены зависимости от уровня триглицеридов (r = 0,57), липопротеидов низкой плотности (r = 0,35), фактора фон Виллебранда (r = 0,55), фибриногена (r = 0,46), фактора свёртывания VIII (r = 0,63), D-димера (r = 0,39), антитромбина III (r = 0,39), соотношения ОТ и объема бёдер (r = 0,53). По итогам построения ROC-кривых триглицерид-глюкозный индекс (ТГИ) определён как предиктор худшего раннего исхода (для ТГИ площадь под кривой 0,66, порог — 4,7), в том числе с учётом ОТ (0,68 и 497,6 соответственно) или тяжести течения (0,63 и 4,7 соответственно).</p> <p><bold>Заключение.</bold> Ишемические инсульты у лиц молодого возраста сопровождаются нарушением метаболического здоровья, которое влияет на исход заболевания. Индексы, включающие глюкозу, триглицериды и статус ожирения, могут иметь предиктивную роль при прогнозировании течения инсультов, в том числе у молодых.</p></trans-abstract><kwd-group xml:lang="en"><kwd>stroke</kwd><kwd>working age</kwd><kwd>obesity</kwd><kwd>prothrombogenic state</kwd><kwd>metabolic indices</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>инсульт</kwd><kwd>трудоспособный возраст</kwd><kwd>ожирение</kwd><kwd>протромбогенное состояние</kwd><kwd>метаболические индексы</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Инсульт: инновационные технологии в лечении и профилактике: руководство для врачей / под ред. М.А. Пирадова, М.М. Танашян, М.Ю. Максимовой. М.; 2024. Piradov MA, Tanashyan MM, Maximova MYu (eds.) Stroke: innovative technologies in treatment and prevention: a guide for doctors. Moscow; 2024.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Stack CA, Cole JW. The clinical approach to stroke in young adults. In: Dehkharghani S (ed.) Stroke. Brisbane; 2021;3. doi: 10.36255/exonpublications.stroke.adultstroke.2021</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Jacob MA, Ekker MS, Allach Y, et al. Global differences in risk factors, etiology, and outcome of ischemic stroke in young adults — a worldwide meta-analysis: the GOAL initiative. Neurology. 2022;98(6):e573-e588. doi: 10.1212/WNL.0000000000013195</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Alkutbi A, Binmahfooz S, Saidlani R, et al. Clinical characteristics of ischemic stroke patients &lt; 50 years old at a university hospital: a retrospective descriptive study. Cureus. 2023;15(8):e43752. doi: 10.7759/cureus.43752</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Гусев В.В., Ковтун О.П., Львова О.А. и др. Анамнестические, клинические и лабораторные особенности течения острого периода ишемического инсульта у пациентов молодого возраст. Неврология, нейропсихиатрия, психосоматика. 2022;14(3):12–18. Gusev VV, Kovtun OP, Lvova OA, et al. Anamnestic, clinical and laboratory features of the acute period of ischemic stroke in young patients. Neurology, Neuropsychiatry, Psychosomatics. 2022;14(3):12–18. doi: 10.14412/2074-2711-2022-3-12-18</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Poisson SN, Hills NK, Sidney S, Fullerton HJ. Prevalence of atherosclerotic risk factors among children and young adults with arterial ischemic stroke. JAMA Neurol. 2022;79(9):901–910. doi: 10.1001/jamaneurol.2022.2077</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Smyth A, Hankey GJ, Damasceno A, et al. Carbonated beverage, fruit drink, and water consumption and risk of acute stroke: the INTERSTROKE case-control study. J Stroke. 2024;26(3):391–402. doi: 10.5853/jos.2024.01543</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Welsh A, Hammad M, Piña IL, Kulinski J. Obesity and cardiovascular health. Eur J Prev Cardiol. 2024;31(8):1026–1035. doi: 10.1093/eurjpc/zwae025</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Frühbeck G, Catalán V, Rodríguez A, Gómez-Ambrosi J. Adiponectin-leptin ratio: a promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk. Adipocyte. 2018;7(1):57–62. doi: 10.1080/21623945.2017.1402151</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Koliaki C, Liatis S, Kokkinos A. Obesity and cardiovascular disease: revisiting an old relationship. Metabolism. 2019;92:98–107. doi: 10.1016/j.metabol.2018.10.011</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Jaakonmäki N, Zedde M, Sarkanen T, et al. Obesity and the risk of cryptogenic ischemic stroke in young adults. J Stroke Cerebrovasc Dis. 2022;31(5):106380. doi: 10.1016/j.jstrokecerebrovasdis.2022.106380</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Pillay P, Lewington S, Taylor H, et al. Adiposity, body fat distribution, and risk of major stroke types among adults in the United Kingdom. JAMA Netw Open. 2022;5(12):e2246613. doi: 10.1001/jamanetworkopen.2022.46613</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Kim DH, Nam GE, Han K, et al. Variabilities in weight and waist circumference and risk of myocardial infarction, stroke, and mortality: a nationwide cohort study. Endocrinol Metab (Seoul). 2020;35(4):933–942. doi: 10.3803/EnM.2020.871</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Liu L, Xue X, Zhang H, et al. Family history, waist circumference and risk of ischemic stroke: a prospective cohort study among Chinese adults. Nutr Metab Cardiovasc Dis. 2023;33(4):758–769. doi: 10.1016/j.numecd.2023.01.009</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>O’Donnell MJ, Chin SL, Rangarajan S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761–775. doi: 10.1016/S0140-6736(16)30506-2</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Gómez-Apo E, Mondragón-Maya A, Ferrari-Díaz M, Silva-Pereyra J. Structural brain changes associated with overweight and obesity. J Obes. 2021;2021:6613385. doi: 10.1155/2021/6613385</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Танашян М.М., Антонова К.В., Лагода О.В. и др. Ожирение и протромбогенное состояние крови у пациентов с цереброваскулярными заболеваниями. Тромбоз, гемостаз и реология. 2023;(3):53–62. Tanashyan MM, Antonova KV, Lagoda OV, et al. Obesity and prothrombotic state in patients with cerebrovascular diseases. Tromboz, gemostaz i reologiya. 2023;(3):53–62. doi: 10.25555/THR.2023.3.1069</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Gui J, Li Y, Liu H, et al. Obesity- and lipid-related indices as a predictor of obesity metabolic syndrome in a national cohort study. Front Public Health. 2023;11:1073824. doi: 10.3389/fpubh.2023.1073824</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Bazyar H, Javid AZ, Masoudi MR, et al. Assessing the predictive value of insulin resistance indices for metabolic syndrome risk in type 2 diabetes mellitus patients. Sci Rep. 2024;14(1):8917. doi: 10.1038/s41598-024-59659-3</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Yang Y, Wang Y, Pei XY. Triglyceride glucose body mass index as 3-year prognostic indicator for major adverse cardiovascular and cerebrovascular events in patients with acute myocardial infarction after PCI: a prospective cohort study. Clin Interv Aging. 2024;19:1341–1350. doi: 10.2147/CIA.S473481</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Dang K, Wang X, Hu J, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003–2018. Cardiovasc Diabetol. 2024;23(1):8. doi: 10.1186/s12933-023-02115-9</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Huang Q, Yin L, Liu Z, et al. Association of novel lipid indicators with the risk of stroke among participants in Central China: a population-based prospective study. Front Endocrinol (Lausanne). 2023;14:1266552. doi: 10.3389/fendo.2023.1266552</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Henning RJ. Obesity and obesity-induced inflammatory disease contribute to atherosclerosis: a review of the pathophysiology and treatment of obesity. Am J Cardiovasc Dis. 2021;11(4):504–529.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Iglesias M, Freuer D, Peters A, et al. Body mass index and waist circumference as determinants of hemostatic factors in participants of a population-based study. Medicina (Kaunas). 2023;59(2):228. doi: 10.3390/medicina59020228</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Танашян М.М., Суслина А., Ионова В.Г. и др. Состояние функции эндотелия у больных с ишемическим инсультом при различной степени атеросклеротического поражения сонных артерий. Неврологический вестник. 2007;39(1):12–16. Tanashyan MM, Suslina ZA, Ionova VG, et al. Endothelium function state in patients with ischemic insult at different forms of carotid arteries atherosclerotic lesion. Neurology bulletin. 2007;39(1):12–16.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Антонова К.В., Танашян М.М., Раскуражев А.А. и др. Ожирение и нервная система. Ожирение и метаболизм. 2024;21(1):68–78. Antonova KV, Tanashyan MM, Raskurazhev AA, et al. Obesity and the nervous system. Obesity and metabolism. 2024;21(1):68–78. doi: 10.14341/omet13019</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Руяткина Л.А., Руяткин Д.С., Исхакова И.С. Возможности и варианты суррогатной оценки инсулинорезистентности. Ожирение и метаболизм. 2019;16(1):27–33. Ruyatkina LA, Ruyatkin DS, Iskhakova IS. Opportunities and options for surrogate assessment of insulin resistance. Obesity and metabolism. 2019;16(1):27–33. doi: 10.14341/omet10082</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Танашян М.М., Антонова К.В., Раскуражев А.А. и др. Цереброваскулярные заболевания и глюколипотоксичность. Анналы клинической и экспериментальной неврологии. 2020;14(1):17–24. Tanashyan MM, Antonova KV, Raskurazhev AA, et al. Cerebrovascular disorders and glucolipotoxicity. Annals of clinical and experimental neurology. 2020;14(1):17–24. doi: 10.25692/ACEN.2020.1.2</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Peng N, Kuang M, Peng Y, et al. Associations between TyG-BMI and normal-high blood pressure values and hypertension: cross-sectional evidence from a non-diabetic population. Front Cardiovasc Med. 2023;10:1129112. doi: 10.3389/fcvm.2023.1129112</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Yu XR, Du JL, Jiang M, et al. Correlation of TyG-BMI and TyG-WC with severity and short-term outcome in new-onset acute ischemic stroke. Front Endocrinol (Lausanne). 2024;15:1327903. doi: 10.3389/fendo.2024.1327903</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Ke P, Wu X, Xu M, et al. Comparison of obesity indices and triglyceride glucose-related parameters to predict type 2 diabetes mellitus among normal-weight elderly in China. Eat Weight Disord. 2022;27(3):1181–1191. doi: 10.1007/s40519-021-01238-w</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Танашян М.М., Антонова К.В. Цереброметаболическое здоровье. В кн.: Аметов А.С. и др. Управление метаболическим здоровьем. М.; 2025. Tanashyan MM, Antonova KV. Сerebrometabolic health. In: Ametov AS, et al. Metabolic health management. Moscow; 2025.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Barakzie A, Jansen AJG, Ten Cate H, de Maat MPM. Coagulation biomarkers for ischemic stroke. Res Pract Thromb Haemost. 2023;7(4):100160. doi: 10.1016/j.rpth.2023.100160</mixed-citation></ref></ref-list></back></article>
